<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A commercially available antigen assay (Pastorex Aspergillus) was used to detect Aspergillus antigen in serial bronchoalveolar lavage (BAL) fluids and sera of patients undergoing bone marrow transplantation (six patients with autopsyproven <z:e sem="disease" ids="C0004030" disease_type="Disease or Syndrome" abbrv="">aspergillosis</z:e> and 10 control patients without evidence of <z:e sem="disease" ids="C0026946" disease_type="Disease or Syndrome" abbrv="">fungal infection</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Aspergillus antigen was not detected in 17 BAL fluids of the six patients with proven <z:e sem="disease" ids="C0004030" disease_type="Disease or Syndrome" abbrv="">aspergillosis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>In two of the six patients the assay gave positive results in serum specimens </plain></SENT>
<SENT sid="3" pm="."><plain>Three of the 10 control patients showed reactive BAL fluids </plain></SENT>
<SENT sid="4" pm="."><plain>It is concluded that the latex agglutination assay of BAL fluids has no value in the diagnosis of invasive (pulmonary) <z:e sem="disease" ids="C0004030" disease_type="Disease or Syndrome" abbrv="">aspergillosis</z:e> in patients undergoing bone marrow transplantation </plain></SENT>
</text></document>